BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 16778838)

  • 1. The co-evolution of host cationic antimicrobial peptides and microbial resistance.
    Peschel A; Sahl HG
    Nat Rev Microbiol; 2006 Jul; 4(7):529-36. PubMed ID: 16778838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are cationic antimicrobial peptides also 'double-edged swords'?
    Ginsburg I; Koren E
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):453-62. PubMed ID: 18662113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial resistance to cationic antimicrobial peptides.
    Anaya-López JL; López-Meza JE; Ochoa-Zarzosa A
    Crit Rev Microbiol; 2013 May; 39(2):180-95. PubMed ID: 22799636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic host defense (antimicrobial) peptides.
    Brown KL; Hancock RE
    Curr Opin Immunol; 2006 Feb; 18(1):24-30. PubMed ID: 16337365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial peptides: a new way to treat bacterial infections].
    Igaz P
    Orv Hetil; 2001 Jan; 142(4):169-71. PubMed ID: 11232153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
    Brogden KA
    Nat Rev Microbiol; 2005 Mar; 3(3):238-50. PubMed ID: 15703760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of antimicrobial peptide action and resistance.
    Yeaman MR; Yount NY
    Pharmacol Rev; 2003 Mar; 55(1):27-55. PubMed ID: 12615953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes.
    Thedieck K; Hain T; Mohamed W; Tindall BJ; Nimtz M; Chakraborty T; Wehland J; Jänsch L
    Mol Microbiol; 2006 Dec; 62(5):1325-39. PubMed ID: 17042784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting back: peptidomimetics as a new weapon in the battle against antibiotic resistance.
    Bragonzi A
    Sci Transl Med; 2010 Mar; 2(21):21ps9. PubMed ID: 20374995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiology: RAMP resistance.
    Buckling A; Brockhurst M
    Nature; 2005 Nov; 438(7065):170-1. PubMed ID: 16281021
    [No Abstract]   [Full Text] [Related]  

  • 11. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides.
    Rosenfeld Y; Sahl HG; Shai Y
    Biochemistry; 2008 Jun; 47(24):6468-78. PubMed ID: 18498177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.
    Tian ZG; Dong TT; Teng D; Yang YL; Wang JH
    Appl Microbiol Biotechnol; 2009 Apr; 82(6):1097-103. PubMed ID: 19148638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids.
    Ernst CM; Peschel A
    Mol Microbiol; 2011 Apr; 80(2):290-9. PubMed ID: 21306448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A linguistic model for the rational design of antimicrobial peptides.
    Loose C; Jensen K; Rigoutsos I; Stephanopoulos G
    Nature; 2006 Oct; 443(7113):867-9. PubMed ID: 17051220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial peptides: their physicochemical properties and therapeutic application.
    Kang SJ; Kim DH; Mishig-Ochir T; Lee BJ
    Arch Pharm Res; 2012 Mar; 35(3):409-13. PubMed ID: 22477186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel antibacterial peptides by chemoinformatics and machine learning.
    Fjell CD; Jenssen H; Hilpert K; Cheung WA; Panté N; Hancock RE; Cherkasov A
    J Med Chem; 2009 Apr; 52(7):2006-15. PubMed ID: 19296598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded.
    Ginsburg I
    Med Hypotheses; 2004; 62(3):367-74. PubMed ID: 14975505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies.
    Hancock RE; Sahl HG
    Nat Biotechnol; 2006 Dec; 24(12):1551-7. PubMed ID: 17160061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of blood components with cathelicidins and their modified versions.
    Yu K; Lai BF; Gani J; Mikut R; Hilpert K; Kizhakkedathu JN
    Biomaterials; 2015 Nov; 69():201-11. PubMed ID: 26295533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial resistance to antimicrobial peptides.
    Abdi M; Mirkalantari S; Amirmozafari N
    J Pept Sci; 2019 Nov; 25(11):e3210. PubMed ID: 31637796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.